1388-1389 / 2605
Trial outcome LA-PC NIRS
• Chemo(radio)therapy elsewhere
– Median survival: 8.5-13 months
– Severe toxicity: 30-50% G4-5
• C-ion+gemcitabine (NIRS high-dose)
– Median survival: >24 months
– Severe toxicity: 3/26 pts G4
• Concurrent gemcitabine at 1,000 mg/m2
Kamada T, et al. Lancet Oncol. 2015 Feb;16(2):e93-e100